PPTA Twitter

Plasma Protein Therapeutics Association

The Plasma Protein Therapeutics Association (PPTA) represents the private sector manufacturers of plasma-derived and recombinant analog therapies, collectively known as plasma protein therapies and the collectors of source plasma used for fractionation. These therapies are used by small patient populations worldwide to treat a variety of rare diseases and serious medical conditions.

Erica XLA

PPTA works globally to:

    • Advocate for access to and affordability of therapies for patients
    • Engage in constructive dialogue with regulatory agencies
    • Collaborate with patient advocacy organizations

PPTA also administers standards and programs that help ensure the quality and safety of plasma collection and manufacturing and protect both donors and patients.

Plasma Collection & Availability of Plasma Products in Europe and the U.S.

  • Each year, millions of plasma donations are made across Europe and the United States at IQPP certified centers. View annual donation totals for Europe and the U.S.
  • Information about the aggregated distribution of plasma protein therapies in the U.S. is provided through PPTA’s North America Distribution Data Program, available here
  • Information about the aggregated distribution of plasma protein therapies in Europe is provided through PPTA’s European Distribution Data Program, available here
Copyright © 2020 PPTA. All rights reserved. (202) 789-3100